CD274 and neoplasm: Preventing TNFα upregulation of PD-L1 and TIM-3 expression by CD8+ tumor infiltrating lymphocytes (TILs) causes reinvigoration of the antitumor immune response, consequently overcoming anti-PD-1 resistance (Figure 2).